Furazolidone

Spécifications

67-45-8Numéro CAS

200-653-3Numéro CE

3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-oneNom IUPAC

C8H7N3O5Formule chimique

225.16 g/molMasse molaire

furazolidone; 67-45-8; Furoxone; Nitrofurazolidone; Furazolidine; Nitrofuroxon; Diafuron; Neftin; Furaxone; Furazolidon; Furoxane; Nifulidone; Furazol; Furazon; Furidon; Nitrofurazolidonum; Furozolidine; Nifurazolidone; Tikofuran; Trichofuron; Tricofuron; Coryzium; Furaxon; Furoxal; Furoxon; Giardil; Giarlam; Medaron; Nicolen; Optazol; Ortazol; Puradin; Roptazol; Topazone; Tricoron; Trifurox; Furall; Furazolidona; Sclaventerol; Corizium; Enterotoxon; Viofuragyn; Bifuron; Furovag; Nifuran; Furox; Furoxone Swine Mix; Usaf ea-1; Furazolidonum; 2-Oxazolidinone, 3-[[(5-nitro-2-furanyl)methylene]amino]-; 3-(5'-Nitrofurfuralamino)-2-oxazolidone; N-(5-Nitro-2-furfurylidene)-3-amino-2-oxazolidone; 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone; NF 180 custom mix ten; Nifurazolidonum; Furazolum; 5-Nitro-N-(2-oxo-3-oxazolidinyl)-2-furanmethanimine; N-(5-Nitro-2-furfurylidene)-3-aminooxazolidine-2-one; 3-((5-Nitrofurylidene)amino)-2-oxazolidone; 3-((5-Nitrofurfurylidene)amino)-2-oxazolidone; 3-((5-Nitrofurfurylidene)amino)-2-oxazolidinone; 3-(((5-Nitro-2-furanyl)methylene)amino)-2-oxazolidinone; NSC-6469; 3-[(5-Nitrofurylidene)amino]-2-oxazolidone; 3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone; 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone; CHEBI:5195; 3-{[(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one; 2-Furanmethanimine, 5-nitro-N-(2-oxo-3-oxazolidinyl)-; 2-Oxazolidinone, 3-(((5-nitro-2-furanyl)methylene)amino)-; 5J9CPU3RE0; 3-{[(5-Nitro-2-furanyl)methylene]amino}-2-oxazolidinone; DTXCID60809632; DTXSID4041997; NSC 6469; AI3-50103; 3-(((5-nitrofuran-2-yl)methylidene)amino)-1,3-oxazolidin-2-one; Dependal-M; RefChem:607782; 3-((5-nitrofuran-2-yl)methylideneamino)-1,3-oxazolidin-2-one; G01AX06; Furox Aerosol Powder, Topazone Aerosol Powder; 200-653-3; 3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one; 3-(5-Nitrofurfurylideneamino)-2-oxazolidinone; MLS000069727; NSC6469; 2-Oxazolidinone, 3-((5-nitrofurfurylidine)amino)-; NF 180; 3-(((5-Nitrofuran-2-yl)methylene)amino)oxazolidin-2-one; 3-[(E)-(5-nitro-2-furyl)methyleneamino]oxazolidin-2-one; NCGC00095304-02; SMR000058228; 2-Oxazolidinone, 3-((5-nitrofurfurylidene)amino)-; Fiurox aerosol powder; (E)-3-(((5-nitrofuran-2-yl)methylene)amino)oxazolidin-2-one; MFCD00010550; Furoxone (TN); FZL; 3-((5-Nitrofurfurylidine)amino)-2-Oxazolidinone; 3-[(5-Nitrofurfurylidine)amino]-2-Oxazolidinone; SR-05000001632; 2-Oxazolidinone, 3-[(5-nitrofurfurylidene)amino]-; 2-Oxazolidinone, 3-[(5-nitrofurfurylidine)amino]-; Furazolidone (USP/INN); Nifulidone;; 3-[(1E)-2-(5-nitro(2-furyl))-1-azavinyl]-1,3-oxazolidin-2-one; Furoxone;; CAS-67-45-8; MFCD00910550; component of Topazone; component of Tricofuron; Furazolidone (Standard); Opera_ID_256; Prestwick2_000808; Prestwick3_000808; Spectrum5_000742; FURAZOLIDONE [MI]; FURAZOLIDONE [INN]; Epitope ID:116184; FURAZOLIDONE [HSDB]; FURAZOLIDONE [IARC]; CHEMBL1103; SCHEMBL64996; BSPBio_000675; BSPBio_002052; FURAZOLIDONE [MART.]; MLS001304180; BIDD:GT0182; FURAZOLIDONE [USP-RS]; FURAZOLIDONE [WHO-DD]; SPECTRUM1500309; BPBio1_000743; orb1224279; HMS500E07; HY-B1336R; 3-[[(5-Nitro-2-furanyl)methylene]-amino]-2-oxazolidinone; FURAZOLIDONE [GREEN BOOK]; MSK4207; 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one; FURAZOLIDONE [ORANGE BOOK]; GLXC-02121; HMS1920O22; HMS2091H03; HMS5083F07; Pharmakon1600-01500309; FURAZOLIDONE [USP IMPURITY]; HY-B1336; FURAZOLIDONE [USP MONOGRAPH]; Tox21_111502; 3-{[(E)-(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one; CCG-40233; EBC-06471; NSC757038; s4528; SBB057396; STK388219; AKOS001678302; Furazolidone, Vetec(TM) reagent grade; MSK4207-1000A; Tox21_111502_1; CCG-266758; CS-4897; DB00614; FF23622; NSC-757038; IDI1_000085; WLN: T5OJ BNW E1UN- AT5NVOTJ; NCGC00095304-01; NCGC00095304-03; NCGC00095304-04; NCGC00095304-05; NCGC00095304-06; NCGC00095304-08; NCGC00188974-01; AC-11695; AC-32486; ST024756; SY076795; SBI-0051388.P003; AB00443658; C07999; C76126; D00830; EN300-122609; AB00052000_03; Furazolidone, VETRANAL(TM), analytical standard; EN300-21037330; Furazolidone Solution in Acetonitrile, 1000ug/mL; Q2467555; SR-05000001632-1; SR-05000001632-3; BRD-K10647544-001-02-0; BRD-K11756522-001-03-2; BRD-K11756522-001-04-0; BRD-K11756522-001-09-9; Z57152562; 3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone, 9CI; 3-([(5-Nitro-2-furyl)methylidene]amino)-1,3-oxazolidin-2-one #; 3-{[(5-NITRO-2-FURYL)METHYLENE]AMINO}-1,3-OXAZOLAN-2-ONE; Furazolidone, United States Pharmacopeia (USP) Reference Standard; 3-[(E)-[(5-nitrofuran-2-yl)methylidene]amino]-1,3-oxazolidin-2-one; InChI=1/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5Synonymes